BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

292 related articles for article (PubMed ID: 23928022)

  • 1. A multicentre evaluation of the effectiveness and safety of high-dose daptomycin for the treatment of infective endocarditis.
    Kullar R; Casapao AM; Davis SL; Levine DP; Zhao JJ; Crank CW; Segreti J; Sakoulas G; Cosgrove SE; Rybak MJ
    J Antimicrob Chemother; 2013 Dec; 68(12):2921-6. PubMed ID: 23928022
    [TBL] [Abstract][Full Text] [Related]  

  • 2. High-dose daptomycin for treatment of complicated gram-positive infections: a large, multicenter, retrospective study.
    Kullar R; Davis SL; Levine DP; Zhao JJ; Crank CW; Segreti J; Sakoulas G; Cosgrove SE; Rybak MJ
    Pharmacotherapy; 2011 Jun; 31(6):527-36. PubMed ID: 21923436
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Daptomycin for the treatment of infective endocarditis: results from a European registry.
    Dohmen PM; Guleri A; Capone A; Utili R; Seaton RA; González-Ramallo VJ; Pathan R; Heep M; Chaves RL
    J Antimicrob Chemother; 2013 Apr; 68(4):936-42. PubMed ID: 23190763
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evaluation of Effectiveness and Safety of High-Dose Daptomycin: Results from Patients Included in the European Cubicin(®) Outcomes Registry and Experience.
    Seaton RA; Menichetti F; Dalekos G; Beiras-Fernandez A; Nacinovich F; Pathan R; Hamed K
    Adv Ther; 2015 Dec; 32(12):1192-205. PubMed ID: 26610384
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Daptomycin for the Treatment of Infective Endocarditis: Results from European Cubicin(®) Outcomes Registry and Experience (EU-CORE).
    Guleri A; Utili R; Dohmen P; Petrosillo N; Piper C; Pathan R; Hamed K
    Infect Dis Ther; 2015 Sep; 4(3):283-96. PubMed ID: 26168988
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Safety and clinical outcomes when utilizing high-dose (> or =8 mg/kg) daptomycin therapy.
    Moise PA; Hershberger E; Amodio-Groton MI; Lamp KC
    Ann Pharmacother; 2009 Jul; 43(7):1211-9. PubMed ID: 19584384
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Efficacy and safety of daptomycin in patients with renal impairment: a multicenter retrospective analysis.
    Kullar R; McClellan I; Geriak M; Sakoulas G
    Pharmacotherapy; 2014 Jun; 34(6):582-9. PubMed ID: 24658897
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Use of daptomycin in complicated cases of infective endocarditis.
    Das I; Saluja T; Steeds R
    Eur J Clin Microbiol Infect Dis; 2011 Jun; 30(6):807-12. PubMed ID: 21327445
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Safety and efficacy of high-dose daptomycin as salvage therapy for severe gram-positive bacterial sepsis in hospitalized adult patients.
    Lai CC; Sheng WH; Wang JT; Cheng A; Chuang YC; Chen YC; Chang SC
    BMC Infect Dis; 2013 Feb; 13():66. PubMed ID: 23379510
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Daptomycin therapy for invasive Gram-positive bacterial infections in children.
    Ardura MI; Mejías A; Katz KS; Revell P; McCracken GH; Sánchez PJ
    Pediatr Infect Dis J; 2007 Dec; 26(12):1128-32. PubMed ID: 18043450
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Daptomycin experience in patients with human immunodeficiency virus and resistant gram-positive infections.
    Slim J; Jimenez H; Culshaw D; Patel H; Lamp KC
    J Int Assoc Provid AIDS Care; 2015; 14(3):202-6. PubMed ID: 25320146
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Multicenter study of high-dose daptomycin for treatment of enterococcal infections.
    Casapao AM; Kullar R; Davis SL; Levine DP; Zhao JJ; Potoski BA; Goff DA; Crank CW; Segreti J; Sakoulas G; Cosgrove SE; Rybak MJ
    Antimicrob Agents Chemother; 2013 Sep; 57(9):4190-6. PubMed ID: 23774437
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical utility of daptomycin in infective endocarditis caused by Gram-positive cocci.
    Cervera C; Castañeda X; Pericas JM; Del Río A; de la Maria CG; Mestres C; Falces C; Marco F; Moreno A; Miró JM
    Int J Antimicrob Agents; 2011 Nov; 38(5):365-70. PubMed ID: 21420835
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A successful salvage therapy with daptomycin and linezolid for right-sided infective endocarditis and septic pulmonary embolism caused by methicillin-resistant Staphylococcus aureus.
    Yazaki M; Oami T; Nakanishi K; Hase R; Watanabe H
    J Infect Chemother; 2018 Oct; 24(10):845-848. PubMed ID: 29534850
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Safety and efficacy of daptomycin in outpatient parenteral antimicrobial therapy: a prospective and multicenter cohort study (DAPTODOM trial).
    Cervera C; Sanroma P; González-Ramallo V; García de la María C; Sanclemente G; Sopena N; Pajarón M; Segado A; Mirón M; Antón F; Basterretxea A; Cuende A; Miró JM;
    Infect Dis (Lond); 2017 Mar; 49(3):200-207. PubMed ID: 27820968
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [The efficacy and safety of daptomycin for the treatment of Gram-positive bacterial infections in Chinese population].
    Zhang L; Li J; Wan X; Shen J; Liu H; Gao H; Liu Z; Wang A
    Zhonghua Nei Ke Za Zhi; 2015 Jun; 54(6):496-500. PubMed ID: 26359009
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A High Daptomycin Dose Is Associated with Better Bacterial Clearance in Infections Caused by Vancomycin-Resistant Enterococcus faecium Regardless of Daptomycin Minimum Inhibitory Concentration in a Rat Infective Endocarditis Model.
    Wang JT; Yang CJ; Yang JL; Lin SW; Chuang YC; Sheng WH; Chen YC; Chang SC
    Microbiol Spectr; 2022 Oct; 10(5):e0255122. PubMed ID: 36190402
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In vivo daptomycin efficacy against experimental vancomycin-resistant Enterococcus faecium endocarditis.
    Reissier S; Saleh-Mghir A; Guerin F; Massias L; Ghout I; Sinel C; Cattoir V; Cremieux AC
    J Antimicrob Chemother; 2018 Apr; 73(4):981-986. PubMed ID: 29329389
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effectiveness and safety of daptomycin in patients with infective endocarditis undergoing heart valve replacement: a subgroup analysis from real-world data.
    Guleri A; Utili R; Dohmen P; Hamed K
    Ther Adv Infect Dis; 2017 Mar; 4(2):41-47. PubMed ID: 28634535
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Daptomycin treatment in Gram-positive vascular graft infections.
    Arnaiz de Las Revillas F; Fernandez-Sampedro M; Arnaiz-García AM; Gutierrez-Cuadra M; Armiñanzas C; Pulitani I; Ponton A; Tascon V; García I; Fariñas MC
    Int J Infect Dis; 2018 Mar; 68():69-73. PubMed ID: 29373845
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.